Global Contraceptive Market: Size, Trends and Forecasts (2018-2022)
Scope of the Report
The report titled “Global Contraceptive Market: Size, Trends and Forecasts (2018-2022)”, provides an in depth analysis of the global contraceptive market by value, by segments, by region, etc. The report also provides a regional analysis of the contraceptive market, including the following regions: North America (the US & Canada), Europe (UK, Germany and Rest of Europe), Asia pacific and ROW.
The report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall global contraceptive market has also been forecasted for the period 2018-2022, taking into consideration the previous growth patterns, the growth drivers and the current and future trends.
The global contraceptive market is highly fragmented with many contraceptive market players operating worldwide. Some contraceptive market players operating on a local level while other contraceptive players operating on a regional and global level. The manufacturers of contraceptive market produce different type of contraceptives, some manufacturers produce contraceptive drugs, some produce contraceptive devices while other produce both contraceptive drugs and devices.
However, the competition in the global contraceptive market is dominated by few contraceptive manufacturers. Further, key players of the contraceptive market are Pfizer, Inc., Bayer AG, Merck & Co, Inc., Allergan Plc. are also profiled with their financial information and respective business strategies.
Country Coverage
Contraception, also referred as birth control, is a method to prevent unwanted pregnancy by restraining with the normal process of fertilization with the help of drugs, barriers, devices and surgical techniques. Contraceptives are the drugs or devices which inhibit unintended pregnancy as well as Sexually Transmitted Diseases (STDs), such as chlamydia, gonorrhea, HIV/AIDS, syphilis, etc. There are various forms of contraceptives available that can be used at different times in the process. Unfortunately, there is no perfect form of contraceptive. There is a failure rate associated with the use of each and every contraceptive.
The benefits of using contraceptive are reduction in pregnancy-related risk, reduction in teenage pregnancies, population control, low risk of sexually transmitted infection, etc. The common side effects associated with the use of contraception are vomiting, weight gain, bleeding between periods or spotting, nausea, breast swelling, urinary tract infection (UTIs), allergies, etc.
Contraceptives have a long history with continuous adoption of effective contraceptives to prevent pregnancy and a shift from traditional contraceptives to modern contraceptives. Presently, contraceptive devices are used by approximately 100 million women across the globe. The contraceptive market can be segmented on the basis of product type and end-user.
The global contraceptive market has increased significantly during the years 2015-2017 and projections are made that the market would rise in the next four years i.e. 2018-2022 tremendously. The contraceptive market is expected to increase due to growing urban population, declining fertility rate, rising number of women at risk for pregnancy, increasing number of women in workforce, surging population with secondary education, etc. Yet the market faces some challenges such as, side effects associated with the contraceptive drugs and devices, lack of social acceptance, less use of contraception among the poor women, etc.
The report titled “Global Contraceptive Market: Size, Trends and Forecasts (2018-2022)”, provides an in depth analysis of the global contraceptive market by value, by segments, by region, etc. The report also provides a regional analysis of the contraceptive market, including the following regions: North America (the US & Canada), Europe (UK, Germany and Rest of Europe), Asia pacific and ROW.
The report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall global contraceptive market has also been forecasted for the period 2018-2022, taking into consideration the previous growth patterns, the growth drivers and the current and future trends.
The global contraceptive market is highly fragmented with many contraceptive market players operating worldwide. Some contraceptive market players operating on a local level while other contraceptive players operating on a regional and global level. The manufacturers of contraceptive market produce different type of contraceptives, some manufacturers produce contraceptive drugs, some produce contraceptive devices while other produce both contraceptive drugs and devices.
However, the competition in the global contraceptive market is dominated by few contraceptive manufacturers. Further, key players of the contraceptive market are Pfizer, Inc., Bayer AG, Merck & Co, Inc., Allergan Plc. are also profiled with their financial information and respective business strategies.
Country Coverage
- North America
- Europe
- Asia Pacific
- ROW
- Pfizer, Inc.
- Bayer AG
- Merck & Co., Inc.
- Allergan Plc.
Contraception, also referred as birth control, is a method to prevent unwanted pregnancy by restraining with the normal process of fertilization with the help of drugs, barriers, devices and surgical techniques. Contraceptives are the drugs or devices which inhibit unintended pregnancy as well as Sexually Transmitted Diseases (STDs), such as chlamydia, gonorrhea, HIV/AIDS, syphilis, etc. There are various forms of contraceptives available that can be used at different times in the process. Unfortunately, there is no perfect form of contraceptive. There is a failure rate associated with the use of each and every contraceptive.
The benefits of using contraceptive are reduction in pregnancy-related risk, reduction in teenage pregnancies, population control, low risk of sexually transmitted infection, etc. The common side effects associated with the use of contraception are vomiting, weight gain, bleeding between periods or spotting, nausea, breast swelling, urinary tract infection (UTIs), allergies, etc.
Contraceptives have a long history with continuous adoption of effective contraceptives to prevent pregnancy and a shift from traditional contraceptives to modern contraceptives. Presently, contraceptive devices are used by approximately 100 million women across the globe. The contraceptive market can be segmented on the basis of product type and end-user.
The global contraceptive market has increased significantly during the years 2015-2017 and projections are made that the market would rise in the next four years i.e. 2018-2022 tremendously. The contraceptive market is expected to increase due to growing urban population, declining fertility rate, rising number of women at risk for pregnancy, increasing number of women in workforce, surging population with secondary education, etc. Yet the market faces some challenges such as, side effects associated with the contraceptive drugs and devices, lack of social acceptance, less use of contraception among the poor women, etc.
1. EXECUTIVE SUMMARY
2. INTRODUCTION
2.1 Contraceptive: An Overview
2.1.1 Different Ways to Use Contraceptive Methods
2.1.2 History of Contraceptives
2.1.3 Benefits of Contraception Use
2.1.4 Contraception: Types and Side Effects
2.2 Contraceptive Segmentation: An Overview
2.2.1 Contraceptive Segmentation by Product Type
2.2.2 Contraceptive Segmentation by End-user
3. GLOBAL MARKET ANALYSIS
3.1 Global Contraceptive Market: An Analysis
3.1.1 Global Contraceptive Market by Value
3.1.2 Global Contraceptive Market by Segments (Contraceptive Devices and Contraceptive Drugs)
3.1.3 Global Contraceptive Market by Region (North America, Europe, Asia Pacific and ROW)
3.2 Global Contraceptive Market: Segment Analysis
3.2.1 Global Contraceptive Drugs Market by Value
3.2.2 Global Contraceptive Devices Market by Value
4. REGIONAL MARKET ANALYSIS
4.1 North America Contraceptive Market: An Analysis
4.1.1 North America Contraceptive Market by Value
4.1.2 North America Contraceptive Market by Region (The US and Canada)
4.2 North America Contraceptive Market: Regional Analysis
4.2.1 The US Contraceptive Market by Value
4.2.2 The US Contraceptive Market by Segments (Hormonal and Non-hormonal)
4.2.3 The US Hormonal Contraceptive Market by Value
4.2.4 The US Hormonal Contraceptive Market by Segments (Oral Contraceptive, Hormonal IUD (Intrauterine Device), Injectable, Vaginal Ring, Implants and Patch)
4.2.5 The US Oral Contraceptive Market by Value
4.2.6 The US Hormonal IUD Contraceptive Market by Value
4.2.7 The US Injectable Contraceptive Market by Value
4.2.8 The US Vaginal Ring Contraceptive Market by Value
4.2.9 The US Implants Contraceptive Market by Value
4.2.10 The US Patch Contraceptive Market by Value
4.2.11 The US Non-Hormonal Contraceptive Market by Value
4.2.12 Canada Contraceptive Market by Value
4.3 Europe Contraceptive Market: An Analysis
4.3.1 Europe Contraceptive Market by Value
4.3.2 Europe Contraceptive Market by Region (Germany, UK and Rest of Europe)
4.4 Europe Contraceptive Market: Regional Analysis
4.4.1 UK Contraceptive Market by Value
4.4.2 Germany Contraceptive Market by Value
4.4.3 Germany Contraceptive Market by Segments (Oral Contraceptive Pills, Injectable Contraceptives and Topical Contraceptives)
4.4.4 Germany Oral Contraceptive Pills Market by Value
4.4.5 Germany Injectable Contraceptive Market by Value
4.4.6 Germany Topical Contraceptive Market by Value
4.4.7 Rest of Europe Contraceptive Market by Value
4.5 Asia Pacific Contraceptive Market: An Analysis
4.5.1 Asia Pacific Contraceptive Market by Value
4.6 ROW Contraceptive Market: An Analysis
4.6.1 ROW Contraceptive Market by Value
5. MARKET DYNAMICS
5.1 Growth Driver
5.1.1 Growing Urban Population
5.1.2 Declining Fertility Rate
5.1.3 Rising Number of Women at Risk for Pregnancy
5.1.4 Falling Prevalence of HIV/AIDS Infection
5.1.5 Increasing Number of Women in Workforce
5.1.6 Surging Population with Secondary Education
5.2 Challenges
5.2.1 Side Effects Associated with the Use of Contraceptive Drugs and Devices
5.2.2 Lack of Social Acceptance
5.2.3 Less Use of Contraception among the Poor Women
5.3 Market Trends
5.3.1 Increasing Adoption Rate of Contraceptive
5.3.2 Contraceptive Program/Methods in Development
5.3.3 Rising Public Awareness and Changing Lifestyle
5.3.4 Easy Availability of Modern Contraceptive
6. COMPETITIVE LANDSCAPE
6.1 Global Contraceptive Market Players: A Financial Comparison
6.2 Global Contraceptive Market Players by Programs in Development
7. COMPANY PROFILES
7.1 Pfizer, Inc.
7.1.1 Business Overview
7.1.2 Financial Overview
7.1.3 Business Strategy
7.2 Bayer AG
7.2.1 Business Overview
7.2.2 Financial Overview
7.2.3 Business Strategy
7.3 Merck & Co., Inc.
7.3.1 Business Overview
7.3.2 Financial Overview
7.3.3 Business Strategy
7.4 Allergan Plc.
7.4.1 Business Overview
7.4.2 Financial Overview
7.4.3 Business Strategy
2. INTRODUCTION
2.1 Contraceptive: An Overview
2.1.1 Different Ways to Use Contraceptive Methods
2.1.2 History of Contraceptives
2.1.3 Benefits of Contraception Use
2.1.4 Contraception: Types and Side Effects
2.2 Contraceptive Segmentation: An Overview
2.2.1 Contraceptive Segmentation by Product Type
2.2.2 Contraceptive Segmentation by End-user
3. GLOBAL MARKET ANALYSIS
3.1 Global Contraceptive Market: An Analysis
3.1.1 Global Contraceptive Market by Value
3.1.2 Global Contraceptive Market by Segments (Contraceptive Devices and Contraceptive Drugs)
3.1.3 Global Contraceptive Market by Region (North America, Europe, Asia Pacific and ROW)
3.2 Global Contraceptive Market: Segment Analysis
3.2.1 Global Contraceptive Drugs Market by Value
3.2.2 Global Contraceptive Devices Market by Value
4. REGIONAL MARKET ANALYSIS
4.1 North America Contraceptive Market: An Analysis
4.1.1 North America Contraceptive Market by Value
4.1.2 North America Contraceptive Market by Region (The US and Canada)
4.2 North America Contraceptive Market: Regional Analysis
4.2.1 The US Contraceptive Market by Value
4.2.2 The US Contraceptive Market by Segments (Hormonal and Non-hormonal)
4.2.3 The US Hormonal Contraceptive Market by Value
4.2.4 The US Hormonal Contraceptive Market by Segments (Oral Contraceptive, Hormonal IUD (Intrauterine Device), Injectable, Vaginal Ring, Implants and Patch)
4.2.5 The US Oral Contraceptive Market by Value
4.2.6 The US Hormonal IUD Contraceptive Market by Value
4.2.7 The US Injectable Contraceptive Market by Value
4.2.8 The US Vaginal Ring Contraceptive Market by Value
4.2.9 The US Implants Contraceptive Market by Value
4.2.10 The US Patch Contraceptive Market by Value
4.2.11 The US Non-Hormonal Contraceptive Market by Value
4.2.12 Canada Contraceptive Market by Value
4.3 Europe Contraceptive Market: An Analysis
4.3.1 Europe Contraceptive Market by Value
4.3.2 Europe Contraceptive Market by Region (Germany, UK and Rest of Europe)
4.4 Europe Contraceptive Market: Regional Analysis
4.4.1 UK Contraceptive Market by Value
4.4.2 Germany Contraceptive Market by Value
4.4.3 Germany Contraceptive Market by Segments (Oral Contraceptive Pills, Injectable Contraceptives and Topical Contraceptives)
4.4.4 Germany Oral Contraceptive Pills Market by Value
4.4.5 Germany Injectable Contraceptive Market by Value
4.4.6 Germany Topical Contraceptive Market by Value
4.4.7 Rest of Europe Contraceptive Market by Value
4.5 Asia Pacific Contraceptive Market: An Analysis
4.5.1 Asia Pacific Contraceptive Market by Value
4.6 ROW Contraceptive Market: An Analysis
4.6.1 ROW Contraceptive Market by Value
5. MARKET DYNAMICS
5.1 Growth Driver
5.1.1 Growing Urban Population
5.1.2 Declining Fertility Rate
5.1.3 Rising Number of Women at Risk for Pregnancy
5.1.4 Falling Prevalence of HIV/AIDS Infection
5.1.5 Increasing Number of Women in Workforce
5.1.6 Surging Population with Secondary Education
5.2 Challenges
5.2.1 Side Effects Associated with the Use of Contraceptive Drugs and Devices
5.2.2 Lack of Social Acceptance
5.2.3 Less Use of Contraception among the Poor Women
5.3 Market Trends
5.3.1 Increasing Adoption Rate of Contraceptive
5.3.2 Contraceptive Program/Methods in Development
5.3.3 Rising Public Awareness and Changing Lifestyle
5.3.4 Easy Availability of Modern Contraceptive
6. COMPETITIVE LANDSCAPE
6.1 Global Contraceptive Market Players: A Financial Comparison
6.2 Global Contraceptive Market Players by Programs in Development
7. COMPANY PROFILES
7.1 Pfizer, Inc.
7.1.1 Business Overview
7.1.2 Financial Overview
7.1.3 Business Strategy
7.2 Bayer AG
7.2.1 Business Overview
7.2.2 Financial Overview
7.2.3 Business Strategy
7.3 Merck & Co., Inc.
7.3.1 Business Overview
7.3.2 Financial Overview
7.3.3 Business Strategy
7.4 Allergan Plc.
7.4.1 Business Overview
7.4.2 Financial Overview
7.4.3 Business Strategy
LIST OF FIGURES
Figure 1: Different Ways to Use Contraceptive Methods
Figure 2: History of Contraceptives
Figure 3: Benefits of Contraception Use
Figure 4: Contraceptive Segmentation by Product Type
Figure 5: Contraceptive Segmentation by End-user
Figure 6: Global Contraceptive Market by Value; 2015-2017 (US$ Billion)
Figure 7: Global Contraceptive Market by Value; 2018-2022 (US$ Billion)
Figure 8: Global Contraceptive Market by Segments; 2017 (Percentage, %)
Figure 9: Global Contraceptive Market by Region; 2017 (Percentage, %)
Figure 10: Global Contraceptive Drugs Market by Value; 2015-2017 (US$ Billion)
Figure 11: Global Contraceptive Drugs Market by Value; 2018-2022 (US$ Billion)
Figure 12: Global Contraceptive Devices Market by Value; 2015-2017 (US$ Billion)
Figure 13: Global Contraceptive Devices Market by Value; 2018-2022 (US$ Billion)
Figure 14: North America Contraceptive Market by Value; 2015-2017 (US$ Billion)
Figure 15: North America Contraceptive Market by Value; 2018-2022 (US$ Billion)
Figure 16: North America Contraceptive Market by Region; 2017 (Percentage, %)
Figure 17: The US Contraceptive Market by Value; 2015-2017 (US$ Billion)
Figure 18: The US Contraceptive Market by Value; 2018-2022 (US$ Billion)
Figure 19: The US Contraceptive Market by Segments; 2017 (Percentage, %)
Figure 20: The US Hormonal Contraceptive Market by Value; 2015-2017 (US$ Billion)
Figure 21: The US Hormonal Contraceptive Market by Value; 2018-2022 (US$ Billion)
Figure 22: The US Hormonal Contraceptive Market by Segments; 2017 (Percentage, %)
Figure 23: The US Oral Contraceptive Market by Value; 2015-2017 (US$ Billion)
Figure 24: The US Oral Contraceptive Market by Value; 2018-2022 (US$ Billion)
Figure 25: The US Hormonal IUD Contraceptive Market by Value; 2015-2017 (US$ Billion)
Figure 26: The US Hormonal IUD Contraceptive Market by Value; 2018-2022 (US$ Billion)
Figure 27: The US Injectable Contraceptive Market by Value; 2015-2017 (US$ Million)
Figure 28: The US Injectable Contraceptive Market by Value; 2018-2022 (US$ Million)
Figure 29: The US Vaginal Ring Contraceptive Market by Value; 2015-2017 (US$ Million)
Figure 30: The US Vaginal Ring Contraceptive Market by Value; 2018-2022 (US$ Million)
Figure 31: The US Implants Contraceptive Market by Value; 2015-2017 (US$ Million)
Figure 32: The US Implants Contraceptive Market by Value; 2018-2022 (US$ Million)
Figure 33: The US Patch Contraceptive Market by Value; 2015-2017 (US$ Million)
Figure 34: The US Patch Contraceptive Market by Value; 2018-2022 (US$ Million)
Figure 35: The US Non-Hormonal Contraceptive Market by Value; 2015-2017 (US$ Billion)
Figure 36: The US Non-Hormonal Contraceptive Market by Value; 2018-2022 (US$ Billion)
Figure 37: Canada Contraceptive Market by Value; 2015-2017 (US$ Billion)
Figure 38: Canada Contraceptive Market by Value; 2018-2022 (US$ Billion)
Figure 39: Europe Contraceptive Market by Value; 2015-2017 (US$ Billion)
Figure 40: Europe Contraceptive Market by Value; 2018-2022 (US$ Billion)
Figure 41: Europe Contraceptive Market by Region; 2017 (Percentage, %)
Figure 42: UK Contraceptive Market by Value; 2015-2017 (US$ Billion)
Figure 43: UK Contraceptive Market by Value; 2018-2022 (US$ Billion)
Figure 44: Germany Contraceptive Market by Value; 2015-2017 (US$ Billion)
Figure 45: Germany Contraceptive Market by Value; 2018-2022 (US$ Billion)
Figure 46: Germany Contraceptive Market by Segments; 2017 (Percentage, %)
Figure 47: Germany Oral Contraceptive Pills Market by Value; 2015-2017 (US$ Billion)
Figure 48: Germany Oral Contraceptive Pills Market by Value; 2018-2022 (US$ Billion)
Figure 49: Germany Injectable Contraceptive Market by Value; 2015-2017 (US$ Million)
Figure 50: Germany Injectable Contraceptive Market by Value; 2018-2022 (US$ Million)
Figure 51: Germany Topical Contraceptive Market by Value; 2015-2017 (US$ Million)
Figure 52: Germany Topical Contraceptive Market by Value; 2018-2022 (US$ Million)
Figure 53: Rest of Europe Contraceptive Market by Value; 2015-2017 (US$ Billion)
Figure 54: Rest of Europe Contraceptive Market by Value; 2018-2022 (US$ Billion)
Figure 55: Asia Pacific Contraceptive Market by Value; 2015-2017 (US$ Billion)
Figure 56: Asia Pacific Contraceptive Market by Value; 2018-2022 (US$ Billion)
Figure 57: ROW Contraceptive Market by Value; 2015-2017 (US$ Billion)
Figure 58: ROW Contraceptive Market by Value; 2018-2022 (US$ Billion)
Figure 59: Global Urban Population by Region; 2013-2017 (Million)
Figure 60: Global Fertility Rate; 2009-2016 (Births per Woman)
Figure 61: Global Adolescent Fertility Rate; 2009-2016 (Births per 1000 women)
Figure 62: The US Women at Risk for Pregnancy; 2017-2022 (Million)
Figure 63: The US Diagnosis of HIV/AIDS Infection; 2011-2016 (Million)
Figure 64: Number of Women in Workforce Worldwide by Age; 2012-2017 (Million)
Figure 65: Female Population Attained Atleast Secondary Education by Region; 2013-2017 (Percentage, %)
Figure 66: Male Population Attained Atleast Secondary Education by Region; 2013-2017 (Percentage, %)
Figure 67: Contraceptive Use by region; 1994-2017 (Percentage, %)
Figure 68: Pfizer, Inc. Revenue; 2013-2017 (US$ Billion)
Figure 69: Pfizer, Inc. Revenue by Segments; 2017 (Percentage, %)
Figure 70: Pfizer, Inc. Revenue by Region; 2017 (Percentage, %)
Figure 71: Bayer AG Sales; 2013-2017 (US$ Billion)
Figure 72: Bayer AG Sales by Segments; 2017 (Percentage, %)
Figure 73: Bayer AG by Region; 2017 (Percentage, %)
Figure 74: Merck & Co., Inc. Sales; 2013-2017 (US$ Billion)
Figure 75: Merck & Co., Inc. Sales by Segments; 2017 (Percentage, %)
Figure 76: Merck & Co., Inc. Sales by Region; 2017 (Percentage, %)
Figure 77: Allergan Plc. Net Revenue; 2013-2017 (US$ Billion)
Figure 78: Allergan Plc. Net Revenue by Segments; 2017 (Percentage, %)
Figure 1: Different Ways to Use Contraceptive Methods
Figure 2: History of Contraceptives
Figure 3: Benefits of Contraception Use
Figure 4: Contraceptive Segmentation by Product Type
Figure 5: Contraceptive Segmentation by End-user
Figure 6: Global Contraceptive Market by Value; 2015-2017 (US$ Billion)
Figure 7: Global Contraceptive Market by Value; 2018-2022 (US$ Billion)
Figure 8: Global Contraceptive Market by Segments; 2017 (Percentage, %)
Figure 9: Global Contraceptive Market by Region; 2017 (Percentage, %)
Figure 10: Global Contraceptive Drugs Market by Value; 2015-2017 (US$ Billion)
Figure 11: Global Contraceptive Drugs Market by Value; 2018-2022 (US$ Billion)
Figure 12: Global Contraceptive Devices Market by Value; 2015-2017 (US$ Billion)
Figure 13: Global Contraceptive Devices Market by Value; 2018-2022 (US$ Billion)
Figure 14: North America Contraceptive Market by Value; 2015-2017 (US$ Billion)
Figure 15: North America Contraceptive Market by Value; 2018-2022 (US$ Billion)
Figure 16: North America Contraceptive Market by Region; 2017 (Percentage, %)
Figure 17: The US Contraceptive Market by Value; 2015-2017 (US$ Billion)
Figure 18: The US Contraceptive Market by Value; 2018-2022 (US$ Billion)
Figure 19: The US Contraceptive Market by Segments; 2017 (Percentage, %)
Figure 20: The US Hormonal Contraceptive Market by Value; 2015-2017 (US$ Billion)
Figure 21: The US Hormonal Contraceptive Market by Value; 2018-2022 (US$ Billion)
Figure 22: The US Hormonal Contraceptive Market by Segments; 2017 (Percentage, %)
Figure 23: The US Oral Contraceptive Market by Value; 2015-2017 (US$ Billion)
Figure 24: The US Oral Contraceptive Market by Value; 2018-2022 (US$ Billion)
Figure 25: The US Hormonal IUD Contraceptive Market by Value; 2015-2017 (US$ Billion)
Figure 26: The US Hormonal IUD Contraceptive Market by Value; 2018-2022 (US$ Billion)
Figure 27: The US Injectable Contraceptive Market by Value; 2015-2017 (US$ Million)
Figure 28: The US Injectable Contraceptive Market by Value; 2018-2022 (US$ Million)
Figure 29: The US Vaginal Ring Contraceptive Market by Value; 2015-2017 (US$ Million)
Figure 30: The US Vaginal Ring Contraceptive Market by Value; 2018-2022 (US$ Million)
Figure 31: The US Implants Contraceptive Market by Value; 2015-2017 (US$ Million)
Figure 32: The US Implants Contraceptive Market by Value; 2018-2022 (US$ Million)
Figure 33: The US Patch Contraceptive Market by Value; 2015-2017 (US$ Million)
Figure 34: The US Patch Contraceptive Market by Value; 2018-2022 (US$ Million)
Figure 35: The US Non-Hormonal Contraceptive Market by Value; 2015-2017 (US$ Billion)
Figure 36: The US Non-Hormonal Contraceptive Market by Value; 2018-2022 (US$ Billion)
Figure 37: Canada Contraceptive Market by Value; 2015-2017 (US$ Billion)
Figure 38: Canada Contraceptive Market by Value; 2018-2022 (US$ Billion)
Figure 39: Europe Contraceptive Market by Value; 2015-2017 (US$ Billion)
Figure 40: Europe Contraceptive Market by Value; 2018-2022 (US$ Billion)
Figure 41: Europe Contraceptive Market by Region; 2017 (Percentage, %)
Figure 42: UK Contraceptive Market by Value; 2015-2017 (US$ Billion)
Figure 43: UK Contraceptive Market by Value; 2018-2022 (US$ Billion)
Figure 44: Germany Contraceptive Market by Value; 2015-2017 (US$ Billion)
Figure 45: Germany Contraceptive Market by Value; 2018-2022 (US$ Billion)
Figure 46: Germany Contraceptive Market by Segments; 2017 (Percentage, %)
Figure 47: Germany Oral Contraceptive Pills Market by Value; 2015-2017 (US$ Billion)
Figure 48: Germany Oral Contraceptive Pills Market by Value; 2018-2022 (US$ Billion)
Figure 49: Germany Injectable Contraceptive Market by Value; 2015-2017 (US$ Million)
Figure 50: Germany Injectable Contraceptive Market by Value; 2018-2022 (US$ Million)
Figure 51: Germany Topical Contraceptive Market by Value; 2015-2017 (US$ Million)
Figure 52: Germany Topical Contraceptive Market by Value; 2018-2022 (US$ Million)
Figure 53: Rest of Europe Contraceptive Market by Value; 2015-2017 (US$ Billion)
Figure 54: Rest of Europe Contraceptive Market by Value; 2018-2022 (US$ Billion)
Figure 55: Asia Pacific Contraceptive Market by Value; 2015-2017 (US$ Billion)
Figure 56: Asia Pacific Contraceptive Market by Value; 2018-2022 (US$ Billion)
Figure 57: ROW Contraceptive Market by Value; 2015-2017 (US$ Billion)
Figure 58: ROW Contraceptive Market by Value; 2018-2022 (US$ Billion)
Figure 59: Global Urban Population by Region; 2013-2017 (Million)
Figure 60: Global Fertility Rate; 2009-2016 (Births per Woman)
Figure 61: Global Adolescent Fertility Rate; 2009-2016 (Births per 1000 women)
Figure 62: The US Women at Risk for Pregnancy; 2017-2022 (Million)
Figure 63: The US Diagnosis of HIV/AIDS Infection; 2011-2016 (Million)
Figure 64: Number of Women in Workforce Worldwide by Age; 2012-2017 (Million)
Figure 65: Female Population Attained Atleast Secondary Education by Region; 2013-2017 (Percentage, %)
Figure 66: Male Population Attained Atleast Secondary Education by Region; 2013-2017 (Percentage, %)
Figure 67: Contraceptive Use by region; 1994-2017 (Percentage, %)
Figure 68: Pfizer, Inc. Revenue; 2013-2017 (US$ Billion)
Figure 69: Pfizer, Inc. Revenue by Segments; 2017 (Percentage, %)
Figure 70: Pfizer, Inc. Revenue by Region; 2017 (Percentage, %)
Figure 71: Bayer AG Sales; 2013-2017 (US$ Billion)
Figure 72: Bayer AG Sales by Segments; 2017 (Percentage, %)
Figure 73: Bayer AG by Region; 2017 (Percentage, %)
Figure 74: Merck & Co., Inc. Sales; 2013-2017 (US$ Billion)
Figure 75: Merck & Co., Inc. Sales by Segments; 2017 (Percentage, %)
Figure 76: Merck & Co., Inc. Sales by Region; 2017 (Percentage, %)
Figure 77: Allergan Plc. Net Revenue; 2013-2017 (US$ Billion)
Figure 78: Allergan Plc. Net Revenue by Segments; 2017 (Percentage, %)
LIST OF TABLES
Table 1: Contraception: Types and Side Effects
Table 2: Contraceptive Program/Methods in Development
Table 3: Global Contraceptive Market Players: A Financial Comparison; 2017
Table 4: Global Contraceptive Market Players by Programs in Development
Table 1: Contraception: Types and Side Effects
Table 2: Contraceptive Program/Methods in Development
Table 3: Global Contraceptive Market Players: A Financial Comparison; 2017
Table 4: Global Contraceptive Market Players by Programs in Development
